Loading...
Please wait, while we are loading the content...
Similar Documents
Amlodipine and valsartan : calcium channel blockers / angiotensin II receptor blockers combination for hypertension
| Content Provider | Semantic Scholar |
|---|---|
| Author | Kjeldsen, Sverre Erik Aksnes, Tonje Amb Sierra, Alex De La Ruilope, Luis M. |
| Copyright Year | 2006 |
| Abstract | 10.2217/14750708.4.1.31 © 20 Despite the availability of numerous antihypertensive agents, many patients with hypertension fail to achieve the blood pressure goals set out in current guidelines. These patients remain at a high risk of cardiovascular morbidity and mortality and require effective treatment options to reduce that risk. Current guidelines recognize that many patients require multiple antihypertensive agents to achieve blood pressure goals. Numerous combination therapies are available, although there is currently no available fixed-dose alternative that combines the benefits of angiotensin receptor blockers and calcium channel blockers. This article explores the rationale for using multiple-mechanism therapy with the angiotensin receptor blocker valsartan and the calcium channel blocker amlodipine and discusses the clinical data supporting this novel approach to the treatment of hypertension. |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://www.openaccessjournals.com/articles/amlodipine-and-valsartan-calcium-channel-blockersangiotensin-ii-receptor-blockers-combination-for-hypertension.pdf |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Amlodipine Angiotensin II receptor antagonist Angiotensin Receptor Antagonists Angiotensins Antihypertensive Agents Calcium Channel Blockers Design rationale High Risk Acute Leukemia Hypertensive disease Morbidity - disease rate Patients benefit valsartan |
| Content Type | Text |
| Resource Type | Article |